
1. Technology overview
Legit.Health offers AI-powered clinical decision support for dermatology. The manufacturer of record on its MDR certificate is AI Labs Group, S.L., in Bilbao, Spain. The company describes its core activity as the design, development and marketing of medical devices that support diagnosis and follow-up by healthcare professionals.
The product analyses a skin photograph with computer vision models and returns a ranked differential diagnosis coded to ICD-11, referral and malignancy indexes, an image quality check and validated severity scores. Reports are delivered as JSON, FHIR or PDF through an app or API embedded in the customer's own system, and a separate research module scores endpoints for clinical trials.
2. Highlighted features & specifications
- Diagnosis support: ranked differential with confidence per condition, coded to ICD-11.
- Referral and malignancy indexes: two routing probabilities with adjustable thresholds.
- Image quality check: scores each image and rejects unusable ones.
- Severity measure: validated scores for treatment choice and monitoring.
- App and API: embeds in the user's system, with reports as JSON, FHIR or PDF.
- Research tools: endpoint scoring, image quality control and a clinical trials app for decentralised capture.
3. Potential application
Provincial hospitals can screen skin lesions photographed at district clinics and refer urgent cases. Private clinic chains can add structured severity scoring for chronic skin disease follow-up. Pharma companies running dermatology trials in the region can use endpoint scoring.
4. Benefits
A ranked differential with confidence values supports diagnosis in primary care and teledermatology. Referral and malignancy indexes with adjustable thresholds help route patients by urgency. Image quality checks reject photos that cannot support a report. Output in FHIR, JSON or PDF fits existing clinical systems.
5. Market trends & opportunities
Dermatology specialist shortages push health systems toward AI-assisted triage and teledermatology. Vietnam and Southeast Asia have limited dermatologist coverage outside major cities, which creates demand for photo-based screening tools that can plug into existing records.
6. Other information
Co-founders listed on the site are Andy Aguilar, Taig Mac Carthy and Gerardo Fernandez. MDR Class IIb certificate MDR 792790 issued by BSI Group The Netherlands (NB 2797), valid to 14 September 2031. Partners shown include QuantifiCare.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































